Geduld E E adds HeartWare International Inc (HTWR) to its portfolio

HeartWare International Inc (HTWR) : Geduld E E added new position in HeartWare International Inc during the most recent quarter end. The investment management firm now holds 10,000 shares of HeartWare International Inc which is valued at $579,400 , the company said in a statement filed on Aug 8, 2016 with the SEC.HeartWare International Inc makes up approximately 0.80% of Geduld E E’s portfolio.

Other Hedge Funds, Including , Alambic Investment Management reduced its stake in HTWR by selling 20,468 shares or 31.69% in the most recent quarter. The Hedge Fund company now holds 44,130 shares of HTWR which is valued at $2,556,892. HeartWare International Inc makes up approx 0.57% of Alambic Investment Management’s portfolio.Swiss National Bank boosted its stake in HTWR in the latest quarter, The investment management firm added 2,000 additional shares and now holds a total of 27,800 shares of HeartWare International Inc which is valued at $1,610,732. Diam Ltd. sold out all of its stake in HTWR during the most recent quarter. The investment firm sold 78,097 shares of HTWR which is valued $4,524,940. Quantbot Technologies Lp sold out all of its stake in HTWR during the most recent quarter. The investment firm sold 2,340 shares of HTWR which is valued $135,580.Cutler Group Lp boosted its stake in HTWR in the latest quarter, The investment management firm added 19,869 additional shares and now holds a total of 41,410 shares of HeartWare International Inc which is valued at $2,386,872. HeartWare International Inc makes up approx 0.16% of Cutler Group Lp’s portfolio.

HeartWare International Inc opened for trading at $57.94 and hit $57.99 on the upside on Monday, eventually ending the session at $57.99, with a gain of 0.09% or 0.05 points. The heightened volatility saw the trading volume jump to 1,79,233 shares. Company has a market cap of $1,018 M.

On the company’s financial health, HeartWare International Inc reported $-0.62 EPS for the quarter, beating the analyst consensus estimate by $ 0.19 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $-0.81. The company had revenue of $68.72 million for the quarter, compared to analysts expectations of $57.36 million. The company’s revenue was down -6.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.47 EPS.

Many Wall Street Analysts have commented on HeartWare International Inc. HeartWare International Inc was Downgraded by Raymond James to ” Mkt Perform” on Jul 13, 2016. HeartWare International Inc was Downgraded by Leerink Partners to ” Mkt Perform” on Jul 11, 2016. HeartWare International Inc was Downgraded by Wells Fargo to ” Market Perform” on Jun 29, 2016.

Heartware International Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices for patients suffering from advanced heart failure. The HeartWare Ventricular Assist System (HVAD System) which includes a ventricular assist device (VAD) or blood pump patient accessories and surgical tools provides circulatory support for patients in the advanced stage of heart failure. The core of the HVAD System is a continuous flow blood pump the HVAD pump. The HVAD System is designed to be implanted adjacent to the heart avoiding abdominal surgery directly adjacent to the heart. The Company’s hybrid system is used for suspending the impeller. The impeller is suspended within the pump housing by the opposing forces of passive magnets and hydrodynamic thrust generated by the pump impeller which circulates a cushion of blood.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *